Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Rank in Stocks #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Share Price
$3.83
Market Cap
$464.45M
Change (1 day)
-1.63%
Change (1 year)
17.17%
Country
TW
Trade Gongwin Biopharm Holdings Co., Ltd. (6617)

Category

Stock split history for Gongwin Biopharm Holdings Co., Ltd. (6617)
Gongwin Biopharm Holdings Co., Ltd. stock (symbol: 6617) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 31, 2026.
One 6617 share bought prior to Aug 31, 2026 would equal to 0 6617 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
11 x12
US
0 -
US
3 x5
AU